An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

Johnson, Sally; Stojanovic, Jelena; Ariceta, Gema; Bitzan, Martin; BEŞBAŞ, NESRİN; Frieling, Michelle; Karpman, Diana; Landau, Daniel; Langman, Craig; Licht, Christoph; Pecoraro, Carmine; Riedl, Magdalena; Siomou, Ekaterini; van de Kar, Nicole; Vande Walle, Johan; Loirat, Chantal; Taylor, C.

doi:10.1007/s00467-014-2817-4

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

Johnson S., Stojanovic J., Ariceta G., Bitzan M., BEŞBAŞ N., Frieling M., ...Daha Fazla

PEDIATRIC NEPHROLOGY, cilt.29, sa.10, ss.1967-1978, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 10
Basım Tarihi: 2014
Doi Numarası: 10.1007/s00467-014-2817-4
Dergi Adı: PEDIATRIC NEPHROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1967-1978
Hacettepe Üniversitesi Adresli: Evet

Özet

In 2009, the European Paediatric Study Group for Haemolytic Uraemic Syndrome (HUS) published a clinical practice guideline for the investigation and initial therapy of diarrhea-negative HUS (now more widely referred to as atypical HUS, aHUS). The therapeutic component of the guideline (comprising early, high-volume plasmapheresis) was derived from anecdotal evidence and expert consensus, and the authors committed to auditing outcome.